filmov
tv
Philippe Moreau
Показать описание
ASH Press Briefing 5 Sunday December 6, 2015:
Philippe Moreau,et al.
727 Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537).
Philippe Moreau,et al.
727 Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537).
0:18:11
0:05:39
0:05:23
0:04:04
0:01:28
0:04:14
0:05:09
0:01:47
1:32:14
1:39:12
0:00:59
0:01:40
0:04:31
0:03:44
0:05:58
0:03:48
0:03:38
0:01:31
0:04:39
0:04:57
0:03:47
0:00:35
0:29:13
0:01:58